News

Vistra Corp. (VST) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Conference Call May 7, 2025 10:00 AM ETCompany ParticipantsEric Micek - VP, IRJim Burke - President ...
Arcutis Biotherapeutics, Inc.: Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update
Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible reset ...